Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04042233 · ClinicalTrials.gov registry record · Phase 4
Intraosseous Vancomycin in Primary Total Hip Arthroplasty - Designing a Protocol
A Phase 4 study, sponsored by The Methodist Hospital Research Institute.
- Completed
- Registry status
- Phase 4
- Development phase
- 23
- Enrollment target
NCT04042233 is a Phase 4 study that has completed, run by The Methodist Hospital Research Institute. The registered enrollment target is 23 participants.
The verdict
NCT04042233, a Phase 4 study, has completed, sponsored by The Methodist Hospital Research Institute.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 23 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate a novel vancomycin intraosseous administration protocol vs a standard IV vancomycin administration protocol for primary total hip arthroplasty patients.
Interventions
- DRUG Experimental Intraosseous vancomycin 500mg in 250 mL NS
- DRUG Standard IV administration of vancomycin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2019-12-31 |
| Est. Completion | 2022-09-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04042233
The ClinicalTrials.gov registry entry for NCT04042233 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Methodist Hospital Research Institute, which has 126 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Experimental Intraosseous vancomycin 500mg in 250 mL NS is the first listed.
NCT04042233 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04042233 about?
NCT04042233 is a clinical study titled "Intraosseous Vancomycin in Primary Total Hip Arthroplasty - Designing a Protocol". The objective of this study is to evaluate a novel vancomycin intraosseous administration protocol vs a standard IV vancomycin administration protocol for primary total hip arthroplasty patients.
What is the current status of trial NCT04042233?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 23 participants. The study started on 2019-12-31. Estimated completion is 2022-09-01.
What interventions are being tested in trial NCT04042233?
The interventions under investigation include: Experimental Intraosseous vancomycin 500mg in 250 mL NS (DRUG), Standard IV administration of vancomycin (DRUG).
Who is sponsoring clinical trial NCT04042233?
This trial is sponsored by The Methodist Hospital Research Institute, which has 126 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.